HEADER TRANSFERASE 04-MAY-17 5NVF TITLE CRYSTAL STRUCTURE OF TNKS2 IN COMPLEX WITH 2-[4-(PYRIDIN-2-YL)PHENYL]- TITLE 2 3,4-DIHYDROQUINAZOLIN-4-ONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TANKYRASE-2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 946-1113; COMPND 5 SYNONYM: TANK2,ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 6,ARTD6, COMPND 6 POLY [ADP-RIBOSE] POLYMERASE 5B,TNKS-2,TRF1-INTERACTING ANKYRIN- COMPND 7 RELATED ADP-RIBOSE POLYMERASE 2,TANKYRASE II,TANKYRASE-LIKE PROTEIN, COMPND 8 TANKYRASE-RELATED PROTEIN; COMPND 9 EC: 2.4.2.30; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: TANKYRASE-2; COMPND 13 CHAIN: H, I; COMPND 14 FRAGMENT: UNP RESIDUES 1114-1162; COMPND 15 SYNONYM: TANK2,ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 6,ARTD6, COMPND 16 POLY [ADP-RIBOSE] POLYMERASE 5B,TNKS-2,TRF1-INTERACTING ANKYRIN- COMPND 17 RELATED ADP-RIBOSE POLYMERASE 2,TANKYRASE II,TANKYRASE-LIKE PROTEIN, COMPND 18 TANKYRASE-RELATED PROTEIN; COMPND 19 EC: 2.4.2.30; COMPND 20 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TNKS2, PARP5B, TANK2, TNKL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: ROSETTA2; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PNIC-BSA4; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: TNKS2, PARP5B, TANK2, TNKL; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_VARIANT: ROSETTA2; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PNIC-BSA4 KEYWDS TANKYRASE, INHIBITOR, ARTD6, PARP5B, ADP-RIBOSYLTRANSFERASE, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.NKIZINKIKO,T.HAIKARAINEN,L.LEHTIO REVDAT 3 17-JAN-24 5NVF 1 REMARK REVDAT 2 16-OCT-19 5NVF 1 REMARK REVDAT 1 14-MAR-18 5NVF 0 JRNL AUTH Y.NKIZINKIKO,J.DESANTIS,J.KOIVUNEN,T.HAIKARAINEN,S.MURTHY, JRNL AUTH 2 L.SANCINETO,S.MASSARI,F.IANNI,E.OBAJI,M.I.LOZA, JRNL AUTH 3 T.PIHLAJANIEMI,J.BREA,O.TABARRINI,L.LEHTIO JRNL TITL 2-PHENYLQUINAZOLINONES AS DUAL-ACTIVITY TANKYRASE-KINASE JRNL TITL 2 INHIBITORS. JRNL REF SCI REP V. 8 1680 2018 JRNL REFN ESSN 2045-2322 JRNL PMID 29374194 JRNL DOI 10.1038/S41598-018-19872-3 REMARK 2 REMARK 2 RESOLUTION. 1.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0155 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.56 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 73797 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.201 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3885 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.55 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.59 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5423 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.79 REMARK 3 BIN R VALUE (WORKING SET) : 0.2870 REMARK 3 BIN FREE R VALUE SET COUNT : 286 REMARK 3 BIN FREE R VALUE : 0.2800 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3347 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 74 REMARK 3 SOLVENT ATOMS : 407 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.17000 REMARK 3 B22 (A**2) : -0.94000 REMARK 3 B33 (A**2) : 1.11000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.072 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.073 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.054 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.536 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.966 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.959 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3602 ; 0.009 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3312 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4871 ; 1.392 ; 1.957 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7609 ; 0.900 ; 3.002 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 439 ; 6.145 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 185 ;31.145 ;22.865 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 602 ;11.116 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;15.989 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 487 ; 0.080 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4136 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 946 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1696 ; 1.237 ; 2.007 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1695 ; 1.234 ; 2.005 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2122 ; 1.970 ; 2.999 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2123 ; 1.970 ; 3.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1906 ; 1.780 ; 2.234 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1906 ; 1.780 ; 2.234 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2739 ; 2.886 ; 3.271 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4058 ; 4.416 ;23.656 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4059 ; 4.416 ;23.653 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5NVF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-MAY-17. REMARK 100 THE DEPOSITION ID IS D_1200004804. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-SEP-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.953723 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 77683 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.550 REMARK 200 RESOLUTION RANGE LOW (A) : 45.560 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.8500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3U9H REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.86 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M LISO4, 0.1 M TRIS HCL, 24/26 % REMARK 280 PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 59.87000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 59.87000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 45.40500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 49.27000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 45.40500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 49.27000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 59.87000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 45.40500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 49.27000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 59.87000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 45.40500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 49.27000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10390 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -69.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6490 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10320 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -69.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B1354 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 923 REMARK 465 HIS A 924 REMARK 465 HIS A 925 REMARK 465 HIS A 926 REMARK 465 HIS A 927 REMARK 465 HIS A 928 REMARK 465 HIS A 929 REMARK 465 SER A 930 REMARK 465 SER A 931 REMARK 465 GLY A 932 REMARK 465 VAL A 933 REMARK 465 ASP A 934 REMARK 465 LEU A 935 REMARK 465 GLY A 936 REMARK 465 THR A 937 REMARK 465 GLU A 938 REMARK 465 ASN A 939 REMARK 465 LEU A 940 REMARK 465 TYR A 941 REMARK 465 PHE A 942 REMARK 465 GLN A 943 REMARK 465 SER A 944 REMARK 465 MET A 945 REMARK 465 LEU A 946 REMARK 465 ASN A 947 REMARK 465 THR A 948 REMARK 465 SER A 949 REMARK 465 GLY A 950 REMARK 465 SER A 951 REMARK 465 MET A 1113 REMARK 465 LYS H 1114 REMARK 465 GLY H 1162 REMARK 465 MET B 923 REMARK 465 HIS B 924 REMARK 465 HIS B 925 REMARK 465 HIS B 926 REMARK 465 HIS B 927 REMARK 465 HIS B 928 REMARK 465 HIS B 929 REMARK 465 SER B 930 REMARK 465 SER B 931 REMARK 465 GLY B 932 REMARK 465 VAL B 933 REMARK 465 ASP B 934 REMARK 465 LEU B 935 REMARK 465 GLY B 936 REMARK 465 THR B 937 REMARK 465 GLU B 938 REMARK 465 ASN B 939 REMARK 465 LEU B 940 REMARK 465 TYR B 941 REMARK 465 PHE B 942 REMARK 465 GLN B 943 REMARK 465 SER B 944 REMARK 465 MET B 945 REMARK 465 LEU B 946 REMARK 465 ASN B 947 REMARK 465 THR B 948 REMARK 465 SER B 949 REMARK 465 GLY B 950 REMARK 465 SER B 951 REMARK 465 LYS I 1114 REMARK 465 GLY I 1162 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH2 ARG H 1128 O HOH H 1301 1.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A1045 CB - CG - OD1 ANGL. DEV. = 5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A1020 56.66 -143.17 REMARK 500 HIS A1021 50.62 39.89 REMARK 500 VAL H1131 -61.34 -137.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1203 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A1081 SG REMARK 620 2 HIS A1084 ND1 109.7 REMARK 620 3 CYS A1089 SG 109.9 103.7 REMARK 620 4 CYS A1092 SG 116.3 102.7 113.6 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B1203 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B1081 SG REMARK 620 2 HIS B1084 ND1 108.4 REMARK 620 3 CYS B1089 SG 108.4 108.9 REMARK 620 4 CYS B1092 SG 118.2 100.2 112.1 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN A 1203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9AW A 1204 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL H 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN B 1203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9AW B 1204 DBREF 5NVF A 946 1113 UNP Q9H2K2 TNKS2_HUMAN 946 1113 DBREF 5NVF H 1114 1162 UNP Q9H2K2 TNKS2_HUMAN 1114 1162 DBREF 5NVF B 946 1113 UNP Q9H2K2 TNKS2_HUMAN 946 1113 DBREF 5NVF I 1114 1162 UNP Q9H2K2 TNKS2_HUMAN 1114 1162 SEQADV 5NVF MET A 923 UNP Q9H2K2 INITIATING METHIONINE SEQADV 5NVF HIS A 924 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF HIS A 925 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF HIS A 926 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF HIS A 927 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF HIS A 928 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF HIS A 929 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF SER A 930 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF SER A 931 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF GLY A 932 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF VAL A 933 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF ASP A 934 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF LEU A 935 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF GLY A 936 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF THR A 937 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF GLU A 938 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF ASN A 939 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF LEU A 940 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF TYR A 941 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF PHE A 942 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF GLN A 943 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF SER A 944 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF MET A 945 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF MET B 923 UNP Q9H2K2 INITIATING METHIONINE SEQADV 5NVF HIS B 924 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF HIS B 925 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF HIS B 926 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF HIS B 927 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF HIS B 928 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF HIS B 929 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF SER B 930 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF SER B 931 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF GLY B 932 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF VAL B 933 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF ASP B 934 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF LEU B 935 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF GLY B 936 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF THR B 937 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF GLU B 938 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF ASN B 939 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF LEU B 940 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF TYR B 941 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF PHE B 942 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF GLN B 943 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF SER B 944 UNP Q9H2K2 EXPRESSION TAG SEQADV 5NVF MET B 945 UNP Q9H2K2 EXPRESSION TAG SEQRES 1 A 191 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 191 GLY THR GLU ASN LEU TYR PHE GLN SER MET LEU ASN THR SEQRES 3 A 191 SER GLY SER GLY THR ILE LEU ILE ASP LEU SER PRO ASP SEQRES 4 A 191 ASP LYS GLU PHE GLN SER VAL GLU GLU GLU MET GLN SER SEQRES 5 A 191 THR VAL ARG GLU HIS ARG ASP GLY GLY HIS ALA GLY GLY SEQRES 6 A 191 ILE PHE ASN ARG TYR ASN ILE LEU LYS ILE GLN LYS VAL SEQRES 7 A 191 CYS ASN LYS LYS LEU TRP GLU ARG TYR THR HIS ARG ARG SEQRES 8 A 191 LYS GLU VAL SER GLU GLU ASN HIS ASN HIS ALA ASN GLU SEQRES 9 A 191 ARG MET LEU PHE HIS GLY SER PRO PHE VAL ASN ALA ILE SEQRES 10 A 191 ILE HIS LYS GLY PHE ASP GLU ARG HIS ALA TYR ILE GLY SEQRES 11 A 191 GLY MET PHE GLY ALA GLY ILE TYR PHE ALA GLU ASN SER SEQRES 12 A 191 SER LYS SER ASN GLN TYR VAL TYR GLY ILE GLY GLY GLY SEQRES 13 A 191 THR GLY CYS PRO VAL HIS LYS ASP ARG SER CYS TYR ILE SEQRES 14 A 191 CYS HIS ARG GLN LEU LEU PHE CYS ARG VAL THR LEU GLY SEQRES 15 A 191 LYS SER PHE LEU GLN PHE SER ALA MET SEQRES 1 H 49 LYS MET ALA HIS SER PRO PRO GLY HIS HIS SER VAL THR SEQRES 2 H 49 GLY ARG PRO SER VAL ASN GLY LEU ALA LEU ALA GLU TYR SEQRES 3 H 49 VAL ILE TYR ARG GLY GLU GLN ALA TYR PRO GLU TYR LEU SEQRES 4 H 49 ILE THR TYR GLN ILE MET ARG PRO GLU GLY SEQRES 1 B 191 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 B 191 GLY THR GLU ASN LEU TYR PHE GLN SER MET LEU ASN THR SEQRES 3 B 191 SER GLY SER GLY THR ILE LEU ILE ASP LEU SER PRO ASP SEQRES 4 B 191 ASP LYS GLU PHE GLN SER VAL GLU GLU GLU MET GLN SER SEQRES 5 B 191 THR VAL ARG GLU HIS ARG ASP GLY GLY HIS ALA GLY GLY SEQRES 6 B 191 ILE PHE ASN ARG TYR ASN ILE LEU LYS ILE GLN LYS VAL SEQRES 7 B 191 CYS ASN LYS LYS LEU TRP GLU ARG TYR THR HIS ARG ARG SEQRES 8 B 191 LYS GLU VAL SER GLU GLU ASN HIS ASN HIS ALA ASN GLU SEQRES 9 B 191 ARG MET LEU PHE HIS GLY SER PRO PHE VAL ASN ALA ILE SEQRES 10 B 191 ILE HIS LYS GLY PHE ASP GLU ARG HIS ALA TYR ILE GLY SEQRES 11 B 191 GLY MET PHE GLY ALA GLY ILE TYR PHE ALA GLU ASN SER SEQRES 12 B 191 SER LYS SER ASN GLN TYR VAL TYR GLY ILE GLY GLY GLY SEQRES 13 B 191 THR GLY CYS PRO VAL HIS LYS ASP ARG SER CYS TYR ILE SEQRES 14 B 191 CYS HIS ARG GLN LEU LEU PHE CYS ARG VAL THR LEU GLY SEQRES 15 B 191 LYS SER PHE LEU GLN PHE SER ALA MET SEQRES 1 I 49 LYS MET ALA HIS SER PRO PRO GLY HIS HIS SER VAL THR SEQRES 2 I 49 GLY ARG PRO SER VAL ASN GLY LEU ALA LEU ALA GLU TYR SEQRES 3 I 49 VAL ILE TYR ARG GLY GLU GLN ALA TYR PRO GLU TYR LEU SEQRES 4 I 49 ILE THR TYR GLN ILE MET ARG PRO GLU GLY HET SO4 A1201 10 HET SO4 A1202 5 HET ZN A1203 1 HET 9AW A1204 23 HET GOL H1201 6 HET SO4 B1201 10 HET SO4 B1202 5 HET ZN B1203 1 HET 9AW B1204 23 HETNAM SO4 SULFATE ION HETNAM ZN ZINC ION HETNAM 9AW 2-(4-PYRIDIN-2-YLPHENYL)-3~{H}-QUINAZOLIN-4-ONE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 5 SO4 4(O4 S 2-) FORMUL 7 ZN 2(ZN 2+) FORMUL 8 9AW 2(C19 H13 N3 O) FORMUL 9 GOL C3 H8 O3 FORMUL 14 HOH *407(H2 O) HELIX 1 AA1 ASP A 962 THR A 975 1 14 HELIX 2 AA2 ASN A 1002 GLU A 1019 1 18 HELIX 3 AA3 PHE A 1035 GLY A 1043 1 9 HELIX 4 AA4 ASP A 1045 ALA A 1049 5 5 HELIX 5 AA5 ASN A 1064 GLN A 1070 1 7 HELIX 6 AA6 GLY A 1074 GLY A 1078 5 5 HELIX 7 AA7 ARG H 1143 GLU H 1145 5 3 HELIX 8 AA8 ASP B 962 THR B 975 1 14 HELIX 9 AA9 ASN B 1002 ASN B 1020 1 19 HELIX 10 AB1 PHE B 1035 GLY B 1043 1 9 HELIX 11 AB2 ASP B 1045 ALA B 1049 5 5 HELIX 12 AB3 ASN B 1064 GLN B 1070 1 7 HELIX 13 AB4 GLY B 1074 GLY B 1078 5 5 HELIX 14 AB5 ARG I 1143 GLU I 1145 5 3 SHEET 1 AA1 5 ILE A 954 ASP A 957 0 SHEET 2 AA1 5 TYR A 992 CYS A1001 -1 O CYS A1001 N ILE A 954 SHEET 3 AA1 5 ALA H1147 ILE H1157 -1 O THR H1154 N LYS A 996 SHEET 4 AA1 5 ARG A1094 THR A1102 -1 N ARG A1094 O TYR H1155 SHEET 5 AA1 5 GLU A1026 HIS A1031 -1 N LEU A1029 O CYS A1099 SHEET 1 AA2 4 ILE A1059 ALA A1062 0 SHEET 2 AA2 4 GLU H1138 ILE H1141 -1 O ILE H1141 N ILE A1059 SHEET 3 AA2 4 SER H1124 PRO H1129 -1 N GLY H1127 O GLU H1138 SHEET 4 AA2 4 SER A1106 SER A1111 1 N GLN A1109 O ARG H1128 SHEET 1 AA3 5 ILE B 954 ASP B 957 0 SHEET 2 AA3 5 TYR B 992 CYS B1001 -1 O LYS B 999 N ILE B 956 SHEET 3 AA3 5 ALA I1147 ILE I1157 -1 O THR I1154 N LYS B 996 SHEET 4 AA3 5 ARG B1094 THR B1102 -1 N ARG B1094 O TYR I1155 SHEET 5 AA3 5 GLU B1026 HIS B1031 -1 N LEU B1029 O CYS B1099 SHEET 1 AA4 4 ILE B1059 ALA B1062 0 SHEET 2 AA4 4 GLU I1138 ILE I1141 -1 O ILE I1141 N ILE B1059 SHEET 3 AA4 4 SER I1124 PRO I1129 -1 N GLY I1127 O GLU I1138 SHEET 4 AA4 4 SER B1106 SER B1111 1 N GLN B1109 O THR I1126 LINK SG CYS A1081 ZN ZN A1203 1555 1555 2.32 LINK ND1 HIS A1084 ZN ZN A1203 1555 1555 2.17 LINK SG CYS A1089 ZN ZN A1203 1555 1555 2.31 LINK SG CYS A1092 ZN ZN A1203 1555 1555 2.30 LINK SG CYS B1081 ZN ZN B1203 1555 1555 2.30 LINK ND1 HIS B1084 ZN ZN B1203 1555 1555 2.13 LINK SG CYS B1089 ZN ZN B1203 1555 1555 2.33 LINK SG CYS B1092 ZN ZN B1203 1555 1555 2.30 SITE 1 AC1 8 ARG A 977 HIS A 979 ARG A 980 LYS A1067 SITE 2 AC1 8 GLN A1070 HOH A1301 HOH H1305 HOH H1318 SITE 1 AC2 6 ASN A 990 ARG A 991 PRO H1160 GLU H1161 SITE 2 AC2 6 HOH H1304 HOH H1319 SITE 1 AC3 4 CYS A1081 HIS A1084 CYS A1089 CYS A1092 SITE 1 AC4 13 HIS A1031 GLY A1032 PHE A1035 ARG A1047 SITE 2 AC4 13 HIS A1048 ALA A1049 TYR A1050 TYR A1060 SITE 3 AC4 13 LYS A1067 SER A1068 TYR A1071 HOH A1415 SITE 4 AC4 13 GLU H1138 SITE 1 AC5 6 PRO H1129 SER H1130 VAL H1131 ASN H1132 SITE 2 AC5 6 GLY H1133 HOH H1301 SITE 1 AC6 8 ARG B 977 HIS B 979 ARG B 980 LYS B1067 SITE 2 AC6 8 GLN B1070 HOH B1301 HOH I1203 HOH I1223 SITE 1 AC7 6 ASN B 990 ARG B 991 PRO I1160 GLU I1161 SITE 2 AC7 6 HOH I1208 HOH I1210 SITE 1 AC8 4 CYS B1081 HIS B1084 CYS B1089 CYS B1092 SITE 1 AC9 14 HIS B1031 GLY B1032 PHE B1035 ARG B1047 SITE 2 AC9 14 HIS B1048 ALA B1049 TYR B1050 TYR B1060 SITE 3 AC9 14 LYS B1067 SER B1068 TYR B1071 ILE B1075 SITE 4 AC9 14 HOH B1394 GLU I1138 CRYST1 90.810 98.540 119.740 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011012 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010148 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008351 0.00000